Top Markets
Coin of the day
Jiangsu Hengrui Medicine Co., Ltd. Jiangsu Hengrui Medicine Co., Ltd.

Jiangsu Hengrui Medicine Co., Ltd.

600276
Classificação em ações #511
Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged... Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged in the full spectrum of pharmaceutical operations, from the initial discovery and development of medications to their manufacturing and worldwide distribution. The company is actively advancing a substantial pipeline of drug candidates, which includes Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403. These prospective treatments are aimed at a diverse range of medical conditions, primarily focusing on oncology, metabolic disorders, pain management, and autoimmune diseases, among others. The enterprise was founded in 1970 and maintains its corporate headquarters in Lianyungang, China.
Preço da ação
$7.90
Valor de mercado
$50.39B
Variação (1 dia)
0.28%
Variação (1 ano)
-9.48%
País
CN
Negociar Jiangsu Hengrui Medicine Co., Ltd. (600276)

Categoria

Histórico de preços das ações de Jiangsu Hengrui Medicine Co., Ltd. (600276)
Preço de fecho mais alto: $7.91 em 2026-08-01

Preço de fecho mais baixo: $0.04 em 2005-07-01
Histórico de preços das ações da Jiangsu Hengrui Medicine Co., Ltd. de 2005 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -3.58%
2025 33.70%
2024 2.96%
2023 15.17%
2022 -30.24%
2021 -37.82%
2020 50.21%
2019 73.88%
2018 25.89%
2017 85.51%
2016 3.95%
2015 100.95%
2014 12.39%
2013 42.52%
2012 4.92%
2011 -16.03%
2010 40.18%
2009 61.62%
2008 -8.70%
2007 153.91%
2006 239.46%
2005 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$171.67 -
DE
$166.06 27.73%
DE
$36.01 21.71%
JP
$228.90 41.12%
CH
$21.45 14.41%
IN